Exploring Psilocybe cubensis Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps
Open Access
- 28 January 2025
- journal article
- review article
- Published by MDPI AG in Journal of Fungi
- Vol. 11 (2) , 99
Abstract
Psilocybe cubensis, a widely recognized psychoactive mushroom species, has played a significant role in both historical and modern therapeutic practices. This review explores the complex interplay between genetic diversity, strain variability and environmental factors that shape the biosynthesis of key psychoactive compounds, including psilocybin and psilocin. With many strains exhibiting substantial variability in their phenotypic characteristics and biochemical content, understanding and documenting this diversity is crucial for optimizing therapeutic applications. The review also highlights advances in cultivation techniques, such as submerged fermentation of the mycelium, and innovative analytical methodologies that have improved the precision of compound quantification and extraction. Although there is limited scientific information on P. cubensis due to nearly four decades of regulatory restrictions on psychedelic research, recent developments in genetic and biochemical studies are beginning to provide valuable insights into its therapeutic potential. Furthermore, this review emphasizes key knowledge gaps and offers insights into future research directions to advance the cultivation, scientific documentation of strain diversity, regulatory considerations and therapeutic use of P. cubensis.Keywords
Funding Information
- Israeli Ministry of Innovation, Science and Technology (1001802444)
This publication has 93 references indexed in Scilit:
- Substrate recognition by the 4‐hydroxytryptamine kinase PsiK in psilocybin biosynthesisFEBS Letters, 2024
- Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA, 2023
- Psychedelic Drug Legislative Reform and Legalization in the USJAMA Psychiatry, 2023
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use DisorderJAMA Psychiatry, 2022
- Genetic Survey of Psilocybe Natural ProductsChemBioChem, 2022
- Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy SubjectsClinical Pharmacology & Therapeutics, 2021
- S‐Adenosyl‐l‐Methionine Salvage Impacts Psilocybin Formation in “Magic” MushroomsChemBioChem, 2019
- Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase‐Enhanced ReactionsChemistry – A European Journal, 2018
- Enzymatic Synthesis of PsilocybinAngewandte Chemie International Edition, 2017
- Magic truffles or Philosopher's stones: a legal way to sell psilocybin?Drug Testing and Analysis, 2012